Targeting mtor substrates in treating proliferative diseases
AssigneePresident and Fellows of Harvard College
InventorsJohn Blenis, Steven P. Gygi, Yonghao Yu
Life of this patent
Estimating the term…
Loading patent…
AssigneePresident and Fellows of Harvard College
InventorsJohn Blenis, Steven P. Gygi, Yonghao Yu
Estimating the term…
Provided are over 300 mTOR kinase targets identified by a comprehensive phosphoproteomics assay. Methods of targeting mTOR kinase targets, methods to determine the level of mTOR activity by measuring the level of phosphorylation of an mTOR targeted phosphorylation site, methods for distinguishing different classes of mTOR activity in a cell based on phosphoproteomic analysis of mTOR-targeted proteins are also provided. Also provided is the classification of a hyperproliferative disease based on phosphoproteomic analysis of mTOR-targeted proteins, as well as the personalization of therapeutic methods for the treatment of hyperproliferative disease based on phosphoproteomics. Also provided are therapeutic methods including administering to a subject an mTOR inhibitor, an mTOR inhibitor and an additional kinase inhibitor, or a dual inhibitor of mTOR and an additional kinase based on the phosphorylation levels of mTOR targets determined in the subject. Some aspects of this invention relate to the discovery that GrblO is an mTOR-targeted tumor suppressor gene.
A method for determining mTOR kinase activity in a cancer cell, the method comprising
8-10. (canceled)
12-13. (canceled)
(canceled)
(canceled)
A method for selecting a treatment of a cancer, the method comprising,
24-40. (canceled)
A method for determining mTOR kinase activity in a cell, the method comprising
42-78. (canceled)
A method for determining mTOR kinase activity in a cell, the method comprising
80-126. (canceled)
A method of identifying an mTOR kinase inhibitor, the method comprising
128-139. (canceled)
A method for determining mTOR kinase activity in a cell, the method comprising
141-148. (canceled)
Dependencies are inferred from the claim text.